Tenders Hamburg

Deadline:September 22, 2026

Rebate Agreement for the active substance Piracetam (ATC N06BX03)

Rebate agreement for the active substance Piracetam (ATC N06BX03) according to § 130a Abs. 8 SGB V: Conclusion of a non-exclusive framework agreement under an Open House model for pharmaceutical companies. The duration is from 01.10.2026 to 30.09.2028, with a 1x12 month extension option. The agreement automatically terminates upon the entry into force of an exclusive contract for the active substance Piracetam. Any pharmaceutical company can join at any time under the same conditions. Required documents include an offer letter, acceptance of DAK-Gesundheit's contractual terms and rebates, and completed Annexes 1 and 2 (Excel file) listing the relevant medicines. Documents must be submitted via email to openhouse@dak.de. For joining on the 1st or 15th of the following month, documents must be submitted by the 5th of the preceding month; further items as per the tender documents.

DAK-Gesundheit

Graffiti Removal for Public Buildings and Areas in Hamburg

Graffiti removal services for public buildings and areas in the Free and Hanseatic City of Hamburg, divided into 5 lots. The services include the removal of graffiti with a maximum value per lot for the entire contract period including extension option.

BVC Behörde für Finanzen und Bezirke

Deadline:September 17, 2026

Rebate Agreement for Budesonide + Formoterol (80 µg/4.5 µg), ATC R03AK07

Non-exclusive rebate agreement according to § 130a Abs. 8 SGB V for the active ingredient Budesonide + Formoterol (exclusively IHP in strength 80 µg/4.5 µg), ATC R03AK07: Conclusion of a framework agreement for pharmaceutical companies at any time under the same conditions; contract duration from 01.10.2026 to 30.09.2028 with one extension option of 1x12 months; submission of documents (offer letter, acceptance of contractual terms, completed Annexes 1 and 2) via email to openhouse@dak.de; Annex 2 must be submitted as an Excel file; for a contract start on 01.10.2026, documents must be submitted by the 5th of the preceding month; later joining is possible at any time, with documents to be submitted by the 5th of the preceding month for joining on the 1st or 15th of the following month; further items as per the tender documents.

DAK-Gesundheit

WLAN Voucher Concession for Internet Access

Service concession for voucher-based internet access: Continuation of WLAN access on existing infrastructure for approximately 87 accommodations.

F&W Fördern & Wohnen AöR

Deadline:August 21, 2026

Non-exclusive rebate agreement for the active ingredient Baclofen (ATC M03BX01)

Non-exclusive rebate agreement for the active ingredient Baclofen (excluding oral dosage forms), ATC M03BX01: Conclusion of a framework agreement for pharmaceutical companies under equal conditions. The contract starts on 01.10.2026, with a term until 30.09.2028, and a renewal option of 1x12 months. Interested parties must submit a letter of offer, acknowledgment of the contractual terms and specified rebates, and completed Annexes 1 and 2 (Excel file) via email to openhouse@dak.de. Documents for a contract start on 01.10.2026 must be submitted by the 5th of the preceding month. Later entries are possible at any time; for an entry on the 1st or 15th of the following month, documents must also be submitted via email by the 5th of the preceding month. Further details on the entry procedure as per the tender documents.

DAK-Gesundheit

Tenders in Hamburg

Hamburg, as a city-state and important economic hub, is a significant public contracting authority. The port, logistics industry, and strong service economy shape the procurement landscape.

With Patterno, find all Hamburg tenders matching your business profile.

Tenders are published on various procurement portals. Patterno aggregates all relevant sources.

Rebate Agreement for Rifaximin (ATC A07AA11) for 2026-2028

Conclusion of a non-exclusive rebate agreement for the active ingredient Rifaximin (ATC A07AA11): Term from October 1, 2026, to September 30, 2028. Any pharmaceutical company may enter into a framework agreement at any time under the same conditions. Required documents include an offer letter, acceptance of DAK-Gesundheit's contractual terms and rebates, and completed Annexes 1 and 2, with Annex 2 to be submitted as an Excel file. Documents must be sent via email to openhouse@dak.de. For a contract start on October 1, 2026, documents must be submitted by the 5th of the preceding month. Later entries are possible at any time, with documents to be submitted by the 5th of the preceding month for an entry on the 1st or 15th of the following month. This procedure is not a formal procurement process and automatically terminates upon the entry into force of an exclusive contract.

DAK-Gesundheit

Deadline:August 05, 2028

Non-exclusive rebate agreement for the active ingredient Abiraterone (excluding 500mg strength)

Non-exclusive rebate agreement according to § 130a para. 8 SGB V for the active ingredient Abiraterone (excluding 500 mg strength, ATC L02BX03): Conclusion of a framework agreement for pharmaceutical companies under equal conditions, with continuous admission possible; contract period from 2026-10-01 to 2027-12-31 with one extension option of 1x12 months. Submission of documents (offer letter, acceptance of contractual terms and rebates, completed annexes 1 and 2, annex 2 as Excel file) via email to openhouse@dak.de by the 5th of the preceding month for the desired contract start. The procedure is not subject to cartel procurement law and terminates upon the entry into force of an exclusive contract. further items as per the tender documents.

DAK-Gesundheit

Deadline:November 05, 2028

Non-exclusive discount agreement for Brimonidine (single-dose)

Conclusion of a non-exclusive discount agreement for the active ingredient Brimonidine (ATC S01EA05) exclusively in single-dose form: Any pharmaceutical company can enter into a framework agreement under the same conditions at any time. The contract period begins on 01.10.2026 and ends on 30.09.2028, with an extension option of 1x12 months. Required documents include an offer letter, acceptance of DAK-Gesundheit's contractual terms and discounts, and completed Annexes 1 and 2, where the medicines must be listed. Annex 2 must be submitted as an Excel file. Documents are to be submitted via email to openhouse@dak.de. For a contract start on 01.10.2026, documents must be submitted by the 5th of the preceding month. Later entries are possible on the 1st or 15th of a month if documents are submitted by the 5th of the preceding month. This procedure is an admission model and does not fall under cartel procurement law.

DAK-Gesundheit

€389,000

Masonry work for energy-efficient refurbishment of Fritz-Schumacher-School

Masonry work for the energy-efficient refurbishment of classroom-type buildings 02, 03, 04, 05, and 08 at the Fritz-Schumacher-School in Hamburg: plinth insulation including earthworks (950 m), internal insulation of basement ceilings (810 m²), breakthroughs in masonry, minor reinforced concrete work (22.7 m³), and internal plastering work (600 m²). The refurbishment aims for the Efficiency House 4 EE (KfW 40) standard and includes a new building envelope in prefabricated timber construction, green roofs with PV systems, conversion of heating supply to heat pumps, renewal of heating surfaces, conversion of cloakrooms into differentiation areas, reorganization of sanitary facilities, installation of barrier-free WCs and tea kitchens, as well as renewal of floor and ceiling coverings and electrical systems. Hazardous material remediation, particularly the removal of asbestos-containing wall and ceiling plaster, is planned before the conversion.

SBH | Schulbau Hamburg

Deadline:September 17, 2026

Rebate agreement for the active substance Formoterol (IHP 6 µg)

Rebate agreement according to § 130a para. 8 SGB V for the active substance Formoterol (exclusively IHP in the strength of 6 µg, ATC R03AC13): Conclusion of a non-exclusive framework agreement under an Open House model for pharmaceutical companies. Contracts first come into effect on 01.10.2026 and end on 30.09.2028, with an extension option of 1x12 months. Required documents include a letter of offer, acceptance of the contractual terms and rebates, and completed annexes 1 and 2, in which the medicinal products must be entered. Documents must be submitted via email to openhouse@dak.de, with Annex 2 as an Excel file. For a contract start on 01.10.2026, documents must be submitted by the 5th of the preceding month; later entries are possible at any time, with documents for an entry on the 1st or 15th of the following month also to be submitted by the 5th of the preceding month. further items as per the tender documents.

DAK-Gesundheit

Rebate agreement for the active ingredient Dydrogesterone (ATC G03DB01)

Rebate agreement for the active ingredient Dydrogesterone (ATC G03DB01): non-exclusive framework agreement according to § 130a para. 8 SGB V, open to all pharmaceutical companies under the same conditions. Duration from 01.10.2026 to 30.09.2028, with an extension option of 1x12 months. Required documents include an offer letter, acceptance of DAK-Gesundheit's contractual terms and rebates, and completed Annexes 1 and 2, in which the relevant medicines must be listed. Submission of documents via email to openhouse@dak.de, Annex 2 as an Excel file. For contract commencement on 01.10.2026, documents must be submitted by the 5th of the preceding month; later entries for the 1st or 15th of the following month also require submission by the 5th of the preceding month. This procedure does not fall under cartel procurement law and terminates upon the entry into force of an exclusive contract from a formal procurement procedure. further items as per the tender documents.

DAK-Gesundheit